Real-world data on the comparison of LDL-C lowering effects between alirocumab and evolocumab. (August 2022) - Lin, D.-Y.; Tsai, C.-L.; Chuang, J.-Y.; Liang, C.-H.; Chen, Y.-H.; Chang, Y.-H.; Yeh, H.-I.; Lin, C.-F.